The combination of lenvatinib and pembrolizumab outperforms sunitinib as first-line
![](https://allmyfamilycare.com/wp-content/uploads/sites/24/2021/02/cfarmafotoConference_News.jpg)
allmyfamilycare.com
The combination of lenvatinib and pembrolizumab outperforms sunitinib as first-line
NOTICE: This Consumer Medicine Information (CMI) is intended for persons